Review Article
Volume 16 Issue 7 - 2021
Latent Tuberculosis Infection, Possibilities of Diagnosis and Treatment in Patients with HIV Infection
Russkikh Oleg Evgenevich*
Associate Professor, Head of the Department of Phthisiology, Izhevsk State Medical Academy of the Ministry of Health of the Russian Federation, Izhevsk, Russia
*Corresponding Author: Russkikh Oleg Evgenevich, Associate Professor, Head of the Department of Phthisiology, Izhevsk State Medical Academy of the Ministry of Health of the Russian Federation, Izhevsk, Russia.
Received: April 27, 2021; Published: July 30, 2021




Abstract

The review presents domestic and foreign literature data on current issues of latent tuberculosis infection (LTBI) and its role in the risk of developing tuberculosis in different population groups, including patients with HIV infection. It has been shown that the greatest risk of developing tuberculosis in persons with LTBI occurs with HIV infection: the annual risk of developing tuberculosis increases by 10%. In the diagnosis of latent tuberculosis infection, allergic skin tests (Mantoux and Diaskintest test), detection of MBT antigens (PCR) and antibodies (ELISA) and in vitro tests based on the production of γ-interferon under the action of various MBT antigens are currently used in the Russian Federation. Based on the results obtained, the tactics and treatment regimen for LTBI were determined. The review presents the main information obtained by domestic and foreign researchers on the results of LTBI treatment to reduce the risk of developing tuberculosis in HIV-infected patients. The article discusses topical issues of chemoprophylaxis of tuberculosis in HIV patients with LTBI, which presents effective treatment regimens aimed at reducing the risk of reactivation of tuberculosis infection, reducing the drug load on the patient and the development of adverse reactions.

The acquisition of new knowledge on the LTBI problem will contribute to the solution of an important task - control over the progression of tuberculosis in HIV-infected patients.

Keywords: Latent Tuberculosis Infection; Chemoprophylaxis; Allergic Skin Tests; Combined Tuberculosis; HIV Infection; LTBI Treatment

References

  1. Gergert VYa and Eremeev VV. “Problems of immunodiagnostics in tuberculosis”. TsNIIT Bulletin 1 (2019): 5-11.
  2. Nechaeva OB. “Monitoring of tuberculosis and HIV infection in the Russian Federation”. Healthcare of the Russian Federation 2 (2012): 18-23.
  3. Bogorodskaya EM., et al. “Anti-tuberculosis work in the city of Moscow. Analytical review of statistical indicators on tuberculosis”. M Mnptsbt (2017): 294s.
  4. Samandari T. “Preliminary results of the Botswana isoniazid preventive therapy (IPT) clinical trial. – In: Proceedings of the 40th Union World Conference on Lung Health”. Mexico (2009).
  5. Litvinov VI. "Dormant" mycobacteria, dormant loci, latent tuberculosis infection”. Tuberculosis and Socially Significant Diseases 2 (2016): 5-13.
  6. Dorozhkova IR. “Latent (latent) tuberculosis infection is a regular phase of persistence of the pathogen in the infected organism”. Tuberculosis and Socially Significant Diseases 2 (2014): 66-78.
  7. Mack U., et al. “LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement”. European Respiratory Journal 33 (2009): 56-73.
  8. Aksenova VA., et al. “Topical issues of mass examination of the child population for tuberculosis in modern conditions”. Ru 8 (2012): 27-29.
  9. Aksenova VA., et al. “Detection of tuberculosis and tactics of dispensary observation of persons from risk groups using a recombinant tuberculosis allergen – Diaskintest”. Moscow (2011).
  10. Sinitsin MV., et al. “Economic efficiency of diagnosis of latent tuberculosis infection and chemoprophylaxis of tuberculosis in patients with HIV infection”. Tuberculosis and Socially Significant Diseases 3 (2018): 4-12.
  11. Akolo C., et al. “Treatment of latent tuberculosis infection in HIV infected persons”. Cochrane Database of Systematic Reviews 20 (2010): CD000171.
  12. Benator D and Bhattacharya M. “Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tubercu7losis in HIV-negative patients: a randomized clinical trial”. Lancet 360 (2002): 528-534.
  13. Slogotskaya LV., et al. “Sensitivity and specifity of new skin with recombinant protein CFP10-ESAT6 in patiens with tuberculosis, and individualis with non-tuberculosis diseases”. European Respiratory Journal 57 (2013): 1995.
  14. Pokrovsky VV., et al. “HIV infection. Federal Scientific and Methodological Center for the Prevention and Control of AIDS”. Newsletter 40 (2015).
  15. Goluba JE., et al. “Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa:a prospective cohort”. AIDS 5 (2009): 631-636.
  16. Slogotskaya LV and Bogorodskaya EM. “Comparative characteristics of immunological tests for detecting tuberculosis infection. The possibility of mass screening”. Tuberculosis and Lung Disease 5 (2016): 5-16.
  17. Menzies D., et al. “Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research”. Annals of Internal Medicine 146 (2007): 340-354.
  18. Rangaka M., et al. “Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis”. The Lancet Infectious Diseases 12 (2012): 45-55.
  19. Parfenova TA. “Experience of using a recombinant tuberculosis allergen in an anti-tuberculosis institution for the diagnosis of tuberculosis infection”. Tuberculosis and Lung Disease 9 (2016): 49-52.
  20. Aksenova VA., et al. “The current state of the issue of tuberculosis morbidity in children, drugs for the prevention and diagnosis of infection. Biologicals”. Prevention, Diagnosis, Treatment 3 (2017): 145-151.
  21. Aksenova VA., et al. “New opportunities for screening and diagnostics of various manifestations of tuberculosis infection in children and adolescents in Russia”. Questions of Modern Pediatrics 4 (2011): 16-22.
  22. Filimonov PN. “Towards a discussion about latent tuberculosis infection”. Tuberculosis and Lung Disease 5 (2014): 69-73.
  23. Al-Orainey I. “Diagnosis of latent tuberculosis: Can we do better?” Annals of Thoracic Medicine1 (2009): 5-9.
  24. Vasilyeva IA., et al. “World Health Organization Global Tuberculosis Reports: Formation and Interpretation”. Tuberculosis and Lung Disease 5 (2017): 7-14.
  25. Slogotskaya LI., et al. “The use of a skin test with a recombinant tuberculosis allergen (Diaskintest®) for the diagnosis of tuberculosis infection in patients with HIV infection”. Pulmonology 1 (2011): 60-64.
  26. Ahmad S. “Pathogenesis, immunology, and diagnosis of latent mycobacterium tuberculosis infection”. Clinical and Developmental Immunology (2011): 17.
  27. Lin M and Ottenhoff T. “Host-pathogen interactions in latent Mycobacterium tuberculosis infection: identification of new targets for tuberculosis intervention”. Endocrine, Metabolic and Immune Disorders - Drug Targets 8 (2008): 15-29.
  28. Getahun H., et al. “HIV infection-associated: The epidemiology and the response”. Clinical Infectious Diseases 50 (2010): 201-207.
  29. Litvinova NV., et al. “Safety and efficacy of rifampicin in the treatment of respiratory tuberculosis with preserved drug sensitivity of the pathogen”. Tuberculosis and Lung Disease 6 (2013): 46-51.
Citation: Russkikh Oleg Evgenevich. “Latent Tuberculosis Infection, Possibilities of Diagnosis and Treatment in Patients with HIV Infection”. EC Nutrition 16.8 (2021): 39-45.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


September Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the September issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before September 28, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk